Immunogenicity risk assessment of synthetic peptide drugs and their impurities
Immunogenicity risk assessment of synthetic peptide drugs and their impurities – ScienceDirect
H1N1 G4 swine influenza T cell epitope analysis in swine and human vaccines and circulating strains uncovers potential risk to swine and humans
Immune Tolerance-Adjusted Personalized Immunogenicity Prediction for Pompe Disease